Cargando…
Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?
Tumor cells detach from the primary tumor or metastatic sites and enter the peripheral blood, often causing metastasis. These cells, named Circulating Tumor Cells (CTCs), display the same spatial and temporal heterogeneity as the primary tumor. Since CTCs are involved in tumor progression, they repr...
Autores principales: | Rossi, Elisabetta, Zamarchi, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811661/ https://www.ncbi.nlm.nih.gov/pubmed/31681412 http://dx.doi.org/10.3389/fgene.2019.00958 |
Ejemplares similares
-
Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
por: Visal, Tanvi H., et al.
Publicado: (2022) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019) -
Cell therapies for Parkinson's disease: how far have we come?
por: Stoker, Thomas B, et al.
Publicado: (2016) -
Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)